Patent · US Active

Deletion mutants of flagellin and methods of use

US9205138B2 · kind B2 · utility

1Cited by
38References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 16, 2014
Grant dateDec 8, 2015
Priority date
Expiry dateDec 16, 2034

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions that include Toll-like Receptor 5 agonists and at least a portion of at least one viral antigen can be employed in methods that stimulate an immune response in a subject, in particular, a protective immune response in a subject. Compositions can be associated with particles and employed in the methods in relatively low doses to provide protective immunity to viral infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.